Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN109053612A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ruthenium-catalyzed route offers mild conditions and significant cost reduction in API manufacturing for high-purity pharmaceutical intermediates supply chain optimization.